RecruitingNot ApplicableNCT07140562

Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation

Prospective, Multi-Center, Single-Arm Study: Safety and Technical Feasibility of the Tangent Tricuspid Annular Therapy System for Transcatheter Valve Repair in Patients With Severe, Symptomatic Functional Tricuspid Regurgitation

Sponsor

Tangent Cardiovascular Inc.

Enrollment

25 participants

Start Date

Jul 15, 2025

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation Tricuspid Regurgitation (TR)Tricuspid Regurgitation Functional

Summary

The goal of this clinical trial is to evaluate the safety and technical success of the Tangent Tricuspid Annular Therapy System in patients with severe, symptomatic functional tricuspid regurgitation.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Tricuspid Annular Therapy System for people with tricuspid regurgitation, tricuspid regurgitation (tr), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETricuspid Annular Therapy System

A transcatheter device designed for tricuspid valve repair.

Locations(1)

Sanatorio Italiano

Asunción, Paraguay

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07140562

Related Trials

Laplace Early Feasibility Study - Canada

NCT071710603 locations

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

NCT0618368410 locations